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Background: Mac1 specificity and bactericidal concentrations may be due to a distinctive membrane disrupting
mechanism.
Results: S. aureus growth is inhibited at 16-fold lower Mac1 concentration than E. coli, but both lipid membranes are compro-
mised at similar concentrations.
Conclusion: Bacteria may cope differently with membrane damage.
Significance: Antimicrobial peptide mode of action needs to be better understood to develop new drug candidate.
Maculatin 1.1 (Mac1) is an antimicrobial peptide from the
skin of Australian tree frogs and is known to possess selectivity
toward Gram-positive bacteria. Although Mac1 has membrane
disrupting activity, it is not known howMac1 selectively targets
Gram-positive over Gram-negative bacteria. The interaction of
Mac1 with Escherichia coli, Staphylococcus aureus, and human
red blood cells (hRBC) and with their mimetic model mem-
branes is here reported. The peptide showed a 16-fold greater
growth inhibition activity against S. aureus (4 M) than against
E. coli (64 M) and an intermediate cytotoxicity against hRBC
(30 M). Surprisingly, Sytox Green uptake monitored by flow
cytometry showed that Mac1 compromised both bacterial
membraneswith similar efficiency at20-fold lower concentra-
tion than the reported minimum inhibition concentration
against S. aureus. Mac1 also reduced the negative potential of
S. aureus and E. coli membrane with similar efficacy. Further-
more, liposomes mimicking the cell membrane of S. aureus
(POPG/TOCL) and E. coli (POPE/POPG) were lysed at similar
concentrations, whereas hRBC-like vesicles (POPC/SM/Chol)
remained mostly intact in the presence of Mac1. Remarkably,
when POPG/TOCL and POPE/POPG liposomes were co-incu-
bated, Mac1 did not induce leakage from POPE/POPG lipo-
somes, suggesting a preference toward POPG/TOCL mem-
branes that was supported by surface plasma resonance assays.
Interestingly, circular dichroism spectroscopy showed a similar
helical conformation in the presence of the anionic liposomes
but not the hRBCmimics. Overall, the study showed that Mac1
disrupts bacterial membranes in a similar fashion before cell
death events and would preferentially target S. aureus over
E. coli or hRBC membranes.
Antimicrobial peptides (AMPs)3 are found in virtually all
organisms including plants, insects, bacteria, and mammals as
part of their innate immune system and act as endogenous anti-
biotics (1). The first AMPs were discovered more than 75 years
ago but have not emerged as commercially viable drug candi-
dates in contrast to naturally occurring small molecule com-
pounds such as penicillin and, more recently, carbapenem.
Because pathogenic bacteria are dangerously gaining the capa-
bility to render almost all antibiotics inefficient by slightlymod-
ifying the structure of targets (often cell receptors or enzymes)
or by reducing the permeability of their lipid membranes (2),
AMPs have regained some interest as drug alternatives. Their
key advantage compared with classic antibiotics comes from
their proposed mode of action, whereby they compromise the
lipid membranes instead of targeting an intracellular and ste-
reo-specific structure (3). AMPs are usually positively charged
and adopt amphipathic structures (e.g. -helical conforma-
tion). These properties are essential for their capacity to insert
into lipid membranes, as is their ability to target the anionic
microbial membrane (4, 5). Indeed, there are major differences
between microbial and mammalian cells, such as lipid mem-
brane composition, transmembrane potential, and the pres-
ence/absence of a cell wall. Bacterial membranes possess high
amounts of negatively charged phospholipids, such as cardioli-
pin (CL) and phosphatidylglycerol (PG) on the outer leaflet (6,
7). In contrast, the outer membrane of mammalian cells is
mainly composed of neutral lipids: cholesterol (Chol), phos-
phatidylcholine (PC) phospholipids, and sphingomyelin (SM)
(8). Therefore, cationicAMPs selectively target and disrupt ani-
onic membranes of bacterial cells over neutral cell membranes
from humans (9). Thus, establishing how AMPs distinguish
between microbes and host cells and, in some cases, between
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Gram-positive and Gram-positive bacteria, is of importance.
Furthermore, the link between compromising the bacterial cell
membrane and the AMP bactericidal effect is often not clear.
This is partially due to the difficulty in matching in vivo and in
vitro conditions with molecular level details.
In this study, we used maculatin 1.1 (Mac1), an AMP
expressed in the skin of the Australian tree frog Litoria geni-
maculata (10), to investigate the link between the membrane
activity of the peptide and the death of bacteria or red blood
cells. Mac1 is a relatively short (21 amino acids) and weakly
cationic (1 net charge) peptide. It has been reported that
Mac1 has weak bactericidal activities against Gram-negative
bacteria and human red blood cells (hRBC) but is highly potent
against Gram-positive bacteria (11). Furthermore, the D-amino
acid enantiomer of Mac1 was shown to have similar activity to
the L-enantiomer, indicating a mode of action independent of a
membrane receptor (12). Previous studies have shown that
Mac1 adopts an -helical secondary structure in contact with
lipid membranes (13). The helical peptide is amphipathic and
can insert into lipid bilayers, eventually forming pores (14).
To gain molecular detail on the interaction of Mac1 with the
lipid bilayer in cell membranes, bioassays with hRBC, Esche-
richia coli, or Staphylococcus aureus were compared with bio-
physical assays performed using membrane models that mim-
icked their respective lipid compositions. TheE. colimembrane
model consisted of POPE/POPG (7:3) (7), S. aureus of POPG/
TOCL (3:2) (6), and red blood cells of POPC/SM/Chol (1:1:1)
(8). Flow cytometry and dye leakage assays were used to deter-
mine the concentration of Mac1 necessary to compromise
membrane integrity, whereas -potential assays monitored the
perturbation on the membrane potentials. The peptide affinity
for a particular lipid membrane composition was followed by
surface plasmon resonance and a novel competitive dye leakage
assay (15). The results were comparedwith the bactericidal and
hemolytic concentrations to discuss the mechanism by which
Mac1 kills bacteria and hRBC.
Experimental Procedures
Materials—Maculatin 1.1 (GLFGVLAKVAAHVVPAIAEHF-
NH2; molecular weight, 2148) at95% purity was purchased
from Federation Bioscience (Melbourne, Australia). Melit-
tin (GIGAVLKVTTGLPALISWIKRKRQQ-NH2; molecular
weight, 2846.5) was purchased from Mimotopes (Mel-
bourne, Australia). The peptide was washed in 5mMHCl and
lyophilized overnight to remove residual trifluoroacetic acid
(16). Palmitoyloleoyl-phosphatidylcholine (POPC), palmi-
toyloleoyl-phosphatidylglycerol (POPG), tetraoeloyl-cardi-
olipin (TOCL), and sphingomyelin (SM) phospholipids were
purchased fromAvanti Polar Lipids (Alabaster, AL) and used
without further purification. LPS purified from E. coli
O127:B8 (L3129; Sigma), cholesterol, 5(6)-carboxyfluores-
cein (CF), and Triton X-100 were purchased from Sigma.
PD-10 columns were purchased from GE Healthcare (VWR,
Brisbane, Australia).
Hemolytic Assay—Hemolysis induced by Mac1 was deter-
mined against hRBC and monitored by hemoglobin release.
Briefly, hRBCswere isolated from fresh blood by centrifugation
at 4000 rpm (1500  g) for 1 min, washed, and diluted in PBS
(137mMNaCl, 2.7 mMKCl, 10mMNa2HPO4, 1.8 mMKH2PO4,
pH 7.4) to a final concentration of 0.25% (v/v). The peptide was
incubatedwith hRBC in a round-bottomed 96-well plate for 1 h
at 37 °C, assayed in triplicate with 2-fold dilutions of peptide
starting from 64 M. After incubation, nonlysed cells were pel-
leted by centrifugation at 1500 rpm (500 g), the supernatant
was transferred to a flat-bottomplate, and released hemoglobin
from lysed cells was quantified by absorbance at 405 nm
(Asample). Melittin, a membrane-permeable and hemolytic
peptide, was used as a positive control. Triton X-100 (0.1%
(v/v)) and PBSwere included to establish 100% (ATriton) and 0%
of lysis (APBS), respectively. The percentage of hemolysis was
calculated using the following equation.
% haemolysis Asample APBS/ATriton APBS 100
(Eq. 1)
Antimicrobial Susceptibility—Susceptibility of bacteria to
Mac1 was considered in terms of bacterial growth inhibition
concentrations. A microtitre broth dilution method was
employed (17). Gram-negativeE. coliATCC25922 (type strain,
smooth LPS), E. coli CGSC 5167 (strain with rough LPS), and
Gram-positive S. aureusATCC 25923 were tested. Briefly, bac-
terial suspensions grown in Mueller Hinton broth (MHB) to
exponential phase (A600 0.5) were diluted to 5 105 cells/ml
in MHB and incubated with 2-fold dilutions of peptides (solu-
bilized in sterile water) in 96-well nonbinding surface plates
(Corning) for 24 h at 37 °C. The minimal inhibitory concentra-
tion (MIC) was the lowest concentration showing no visible
growth. The ability to inhibit growth was further confirmed by
adding 30 l of resazurin dye (0.01% (w/v)) to each well. The
plates were incubated at 37 °C for further 18 h.Wells with pink
coloration indicate reduction of resazurin and, therefore, bac-
terial growth, whereas blue coloration indicates death of organ-
isms or not enough organisms to reduce resazurin (18). The
MIC value is the lowest peptide concentration of the wells with
blue coloration. The assays were done in triplicate.
Cytotoxicity Studies against Cultured Cells—Cervical cancer
(HeLa) and breast cancer (mcf-7) cells were grown in T175
flasks with DMEM (supplemented with 10% (v/v) of fetal
bovine serum and 1% (w/v) penicillin/streptomycin) and incu-
bated in humidified atmosphere at 37 °C with 5% CO2. The day
before the assay, cellswere seeded (5 103 cells/well) in 96-well
flat-bottomed plates. Mac1 andmelittin were incubated for 2 h
in concentrations ranging from40 to 0.35M (final volume, 100
l) in media without serum to avoid degradation. Controls
without peptide or with Triton X-100 (0.01% (v/v) were
included to establish 0 and 100% cell death, respectively. After
2 h of incubation, the peptide was removed, and the cells were
washed with PBS. Fresh medium containing serum and resaz-
urin dye (0.02% w/v) was added to the cells and incubated for
18 h. Absorbance was measured at 540 and 620 nm, and the
percentage of cell deathwas determined as described elsewhere
(18).
Microbial Membrane Permeabilization Detection by SYTOX
Green Fluorescence Emission—E. coli ATCC 25922 and
S. aureus ATCC 25923 cells with compromised membranes
were detected with SYTOXGreen (Invitrogen), a DNA-bind-
Mac1 Lyses Cell Membranes with a Similar Mechanism
19854 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 32•AUGUST 7, 2015
 at UQ Library on July 17, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ing dye that becomes fluorescent when bound to nucleic acids
and only enters cells with a compromised plasma membrane
(19). E. coli or S. aureus bacterial suspensions were grown in LB
or MHB to exponential phase (A600  0.5). Cell suspensions
were diluted to 107 cells/ml in MHB or in PBS. Bacterial sus-
pensions in either PBS or MHB were incubated with Mac1 at
different concentrations (4-fold dilutions from 64M) for 1 h at
37 °C with shaking. Sytox Green (2 M) was incubated with
peptide-treated cells for 10 min, and the fluorescence emission
signal was evaluated by flow cytometry. The population of cells
was selected based on forward scatter and side scattermeasure-
ments. Cells with compromised membranes were identified by
fluorescence (excitationwith 488-nm laser and detection at 530
nm with 30-nm bandpass). Mean fluorescence emission signal
and percentage of fluorescent cells was determined by screen-
ing 50,000 cells. Each experiment was repeated at least three
times. Flow cytometry measurements were performed with a
BD FACSCanto II (BD Biosciences).
To examine whether cell permeability is inversely correlated
with cell viability, peptide-treated and untreated samples with
appropriate dilutions were spread in LB agar plates, and colony
formation units were counted after 24 h incubation at 37 °C.
The experiment was conducted six times.
CF Encapsulation in Large Unilamellar Vesicles—Large
unilamellar vesicles encapsulating CF were prepared by sus-
pending lipid films to 15 mM phospholipid in CF buffer (55 mM
CF, 40 mM imidazole, 1 mM EDTA, adjusted to pH 7.4 with
KOH and HCl). Solutions were freeze/thawed five times and
then extruded 10 times through anAvantiMini-Extruder using
0.1-m polycarbonate filters to produce LUV of a nominal
100-nm diameter. Samples were extruded above the corre-
sponding main gel to fluid chain melting temperatures of the
phospholipids. Nonencapsulated dye was removed by gel filtra-
tion using a PD-10 desalting columnwith a 2.5-ml dead volume.
1 ml of each CF-loaded LUV lipid system was eluted under
gravity with running buffer (40 mM imidazole, 110 mM KCl, 1
mM EDTA, pH 7.4). Approximately 2 ml was collected after
passing 2.5 ml of running buffer. CF-free LUV were prepared
similarly as CF-loaded LUV except that the lipid mixtures were
suspended with 1 ml of the running buffer to reach a 15 mM
stock concentration. Phospholipid concentrations were deter-
mined in triplicate using a modified phosphorus assay as
described previously (15).
CF Release Measurements in Single and Competitive Lipid
Environments—Samples were prepared by mixing a 1:1 molar
ratio of CF-loaded and CF-free vesicles and an appropriate
amount of peptide stock solution to produce desired lipid to
peptidemolar ratios.Negative controlsweremade by substitut-
ing peptide stock for buffer-only and positive controls by add-
ing Triton X-100 to a final 0.1% (v/v) concentration.
Measurements were made on a FLUOstar Optima plate
reader (BMG Labtech) using a Falcon96 tissue culture 96-well
plate (Fisher). The excitationwavelengthwas set at 492 nm, and
the bottom-read emission was recorded at 520 nm. 10 reads
(120 s cycle time) were performed at 30 °C with 5 s of orbital
shaking prior to each cycle, and the fluorescence intensities
were then averaged.
The percentage of CF fluorescence was obtained by normal-
izing the averaged intensities (I) against negative (baseline, Imin)
and positive (100% release, Imax) controls, according to the fol-
lowing equation.
%fluorescence 100  I Imin/Imax Imin (Eq. 2)
The normalized intensities were plotted against the lipid to
peptide molar ratio and fitted using an empirical logistic
function,
F  Fmax Fmax Fmin/1 x/x0
p (Eq. 3)
where F is the normalized intensity at each lipid to peptide
ratio; Fmin and Fmax are fixed at 0 and 100%, respectively; x is the
peptide concentration; x0 is the peptide concentration neces-
sary to obtain 50% of maximal fluorescence (LC50); and p is a
cooperativity factor (15).
Circular Dichroism Spectroscopy—Mac1 stock solutions of 1
mg/mlwere prepared by dissolving lyophilized powder into CD
buffer (20 mM phosphate, 1 mM NaCl, pH 7.4). The stock solu-
tion was sonicated (10 s) and vortexed prior to each use. LUV
vesicles were prepared as described above for CF-free vesicles,
except that lipid systemswere resuspended into CDbuffer. The
lipid suspensionwas homogenized by extrusion to obtain LUVs
with a diameter of 200 nm (10 times through polycarbonate
membranes with 200-nm diameter pores). The size of the LUV
was confirmed by dynamic light scattering. Peptide and LUV
solutions were mixed to obtain samples with 160 l of volume
and 100 M Mac1.
CD spectrawere acquired on aChirascan spectropolarimeter
(Applied Photophysics Ltd, UK) between 180 and 260 nmusing
a 0.1-mm-path length cylindrical quartz cell (Starna, Hainault,
UK). Spectra were acquired with 1-nm data intervals, 1-s inte-
gration time, and 2-scan accumulation. The signal was
recorded as millidegrees at 25 °C. Spectra were zeroed at 260
nm and normalized to give units of mean residue ellipticity
(MRE) according to [	]MRE  	/(c  l  Nr), where 	 is the
recorded ellipticity in millidegrees, c is the peptide concentra-
tion in dmolliter	1, l is the cell path length in cm, andNr is the
number of residues. The helical percentage (H) was calculated
from the Luo-Baldwin formula [2],
H %  	222 nm 	c/	


222 nm 	C (Eq. 4)
where 	C  2200–53T, 	∞222 nm  (	44,000  250 T)(1 	
k/NResidues), withT in °C and k 4 as described for unrestricted
peptides (20).
-PotentialMeasurements—LUVwere prepared as described
in the CD section, except that 5 and 50 mM NaCl concentra-
tions were used. Appropriate volumes of LUV (200 nm diame-
ter) and Mac1 were mixed to produce individual samples at
the desired lipid to peptide molar ratio and then transferred
into a disposable cell (Malvern DTS 1060C) for -potential
measurements.
-Potential measurements were performed using a Malvern
etasizer Nano ZS apparatus (Malvern, UK) with backscatter-
ing detection at 173° and a constant voltage of 40 V. Measure-
ments were performed in triplicate at 25 °C with 100 runs aver-
aged per experiment. The viscosity and refractive index were
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set at 0.8872 cP and 1.550, respectively. The monomodal anal-
ysis mode provided by the Malvern software was used to mea-
sure the -potential upon Mac1 titration.
Peptide Membrane Binding Followed by Surface Plasmon
Resonance—The affinity of Mac1 for model membranes com-
posed of POPC/Chol/SM (1:1:1 molar ratio), POPE/POPG
(7:3), and POPG/CL (3:2) was compared using surface plasmon
resonance. A BIAcore 3000 system (Biacore, GE Healthcare)
and a L1 Sensor Chip were used. Solutions were freshly pre-
pared and filtered using a 0.22-m-pore size filter. Small unila-
mellar vesicles (diameter, 50 nm) prepared by freeze-thaw frac-
turing and sized by extrusion were deposited onto the L1 Chip
as previously described (21). Mac1 samples with different con-
centrations were injected over deposited lipid bilayers as
described previously (22). Allmeasurements were conducted at
25 °C; 10 mM HEPES buffer containing 150 mM NaCl, pH 7.4,
was used as running buffer and to prepare vesicle suspensions
and peptide samples. The lipid deposited onto the chip surface
is dependent on the lipid mixture; therefore, for a more accu-
rate comparison of the binding affinity for the different lipid
mixtures, the response units were converted into peptide to
lipid ratio (mol/mol) as described (23).
Results
Mac1 Has Antimicrobial Activity against S. aureus and
E. coli and Low Hemolytic and Anticancer Activity—Mac1
displayed 10-fold greater potency for inhibiting growth of
S. aureus than E. coli (Table 1), with MIC of 4 and 64 M,
respectively. These results are in agreement with previous
reports suggesting thatMac1 is selective toward Gram-positive
bacteria. Such preference was suggested to correlate with
higher amount of negatively charged lipids in Gram-positive
when compared with Gram-negative bacteria (24). Mac1 is less
efficient in inhibiting the growth of bacteria than the bee venom
peptide melittin, also known for its antimicrobial activity (25),
with the latter inhibiting bacterial growth at 2 and 0.5 M
against E. coli and S. aureus, respectively (Table 1). Notably,
a 4-fold greater potency against Gram-positive was also
observed.
When incubated in growth medium with higher salt content
(LB medium), MIC for both Mac1 and melittin were highly
increased. Mac1 and melittin have been used in many experi-
ments without showing any solubility or secondary structure
perturbations in buffer with up to 150 mM NaCl (14, 15, 25).
Therefore, it may be that bacteria are able to withstand harsh
membrane damage in high salt (LB) compared with low salt
growth medium (MHB).
An E. coli resistant strain with a rough LPS (no O-antigen
chain) was used to investigate the effect of LPS at the outer
membrane interface.Mac1 andmelittinwere both 10- and 100-
fold more potent, respectively, at inhibiting the growth of the
mutant compared with the E. coli type strain.
The effect of Mac1 on eukaryotic target hRBC was also eval-
uated using hemolytic assays. Although not hemolytic at con-
centrations that inhibit S. aureus growth, the concentration
required to lyse 50% of hRBC (HC50) is higher than the MIC
against E. coli type strain (Table 1). However, the number of
bacteria is greater than the number of RBC by 17-fold, and
therefore, at an equivalent hRBC concentration, Mac1 concen-
tration would be extrapolated to be 17-fold greater. Consider-
ing the surface area of the RBC,120-fold greater than the area
of a spherical S. aureus bacterium (1.1 m2) and 40-fold for
E. coli (3.5 m2), the greater HC50 can also be explained by
the greater amount of peptide necessary to cover the lipid
membrane of RBCs versus bacteria. Although this would put
the MIC against S. aureus within the same range, it does not
correlate well with theMIC against E. coli strains. In contrast to
the anionicmicrobialmembrane surface, the outer leaflet of the
hRBC membrane is mainly composed of zwitterionic lipids,
producing a net neutralmembrane. These observations suggest
a preference toward negatively charged membranes over neu-
tral membranes and that the lipid composition of the bacterial
membranes plays a critical role in the antimicrobial activity of
Mac1. Such interpretations are in agreement with previous
studies (4, 13).
Finally, the activity of Mac1 was also tested against two cul-
tured cancer lines: cervical (HeLa) and breast (mcf-7) cancer
cells (Fig. 1). Cancer cells are known to have a more negative
membrane surface compared with healthy cells, and therefore,
cationic AMPs have been investigated as potential anticancer
agents (26). The concentration of Mac1 required to kill 50% of
TABLE 1
Bactericidal, hemolytic, and anticancer activities and permeabilization to SYTOX Green induced by Mac1
All values are given in M.
E. coli ATCC 25922 E. coli CGSC 5167 S. aureus ATCC 25923
MICa
Mac1 64 (16–32)b 4–8 4 (16–64)b
Melittin 2 (32)b 0.02 0.5 (32)b
SYTOX Green uptakec
Mac1 4.5 0.5 (45.4 2.9)d 2.1 0.1 3.6 0.3 (23.7 3.0)d
Melittin 0.3 0.1 (1.7 0.1)d 0.11 0.01 0.3 0.1 (1.0 0.1)d
Haemolytic and anticancer activitye HeLa MCF-7 hRBC
Mac1 32 23.0 0.30 29.5 1.0
Melittin 1.1 0.1 0.6 0.1 1.2 0.1
aMIC values were obtained with resazurin and tested in triplicate with 5 105 cells/ml in MHB medium.
bMIC values were obtained with resazurin and tested in triplicate with 5 105 cells/ml in LB medium.
c LC50 (concentration required to lyse 50% of the cells) was obtained in triplicate and followed by flow cytometry with 107 cells/ml. Mac1 was incubated with bacteria in PBS
for 1 h at 37 °C, before the addition of SYTOX Green.
dMac1 was incubated with bacteria in MHB for 1 h at 37 °C, washed, and resuspended in PBS before the addition of SYTOX Green.
e CC50 (concentration required to kill 50% of the cancer cells) was determined with 5 103 cells/well HeLa or MCF-7. HC50 (concentration required to induce lysis in 50% of
the RBCs) was determined in triplicate with 0.25% (v/v) RBCs (3 104 cells/ml). HC50, CC50, and LC50 and respective S.D. were obtained by fitting the data with a sig-
moidal curve.
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the cells (CC50) was 32 and 23 M against HeLa and mcf-7
cells, respectively (Fig. 1 and Table 1). The dose-response
curves and toxicity values were close to those found for hemo-
lytic activity, suggesting a similar mode of action, probably de-
pendent on membrane disruption. The activity against human
cells suggests that electrostatic interactions alone are not suffi-
cient to explain the lytic activity of Mac1 against cell mem-
branes.Melittin, a peptide known to act through cellmembrane
disruption, had high toxicity against both cell lines, with CC50
values of 1.1 and 0.6 M against HeLa and mcf-7, respectively.
Mac1 Permeates E. coli and S. aureus Membranes at Similar
Concentrations—To further investigate the hypothesis that
Mac1 kills the bacteria bymembrane disruption, themembrane
permeability to SYTOX Green dye was investigated using flow
cytometry. SYTOX Green is nonfluorescent in aqueous envi-
ronment but becomes fluorescent when interacting with
nucleic acids and can only enter cells if membranes are com-
promised (19). Fig. 2 shows that 3 M of Mac1 can permeate
50% of S. aureus bacteria (LC50), and surprisingly, approxi-
mately the same concentrationwas required against E. coli type
strain bacteria and just slightly lower against the rough LPS
E. coli strain (2.1M). Such findings were not expected, consid-
ering the higher MIC obtained with E. coli type strain bacteria.
Also, the population of viable bacteria incubated with Mac1
correlated with the percentage of nonpermeabilized mem-
branes (Fig. 2).
To determine whether the growth medium had an effect,
these experiments were repeated by incubating the peptide
with bacterial suspensions in MHB, instead of PBS. The con-
centration of Mac1 necessary to induce permeabilization in
50% of the cells increased by 10-fold against E. coli and 7-fold
against S. aureus. Similarly, an increase was observed with
melittin: 6-fold against E. coli and 4-fold against S. aureus
(Table 1). Overall, the analogous increase in LC50 observed for
both peptides against S. aureus and E. coli was consistent with
the assay performed in PBS, and the greater concentrations are
most likely due to the ongoing replication in nutrient-rich
medium, whereas bacteria are not able to replicate in PBS.
Strikingly, if the generation time (15 min for E. coli and 30
min for S. aureus) is considered, the concentration of Mac1
necessary to lyse 107 cells/ml is approximately the same against
both strains, 11 M, and slightly greater than in PBS. Although
FIGURE 1.Cytotoxicity ofMac1.A–C, dose response against hRBC (A), HeLa cells (B), andMCF-7 cells (C). Human red blood cells (3 104 cells/ml) and cancer
cells (5 103 cells/well seeded in the day before)were incubatedwith various concentrations of peptide at 37 °C for 1 h (red blood cells) or 2 h (HeLa andmcf-7
cells). The percentage of hemolysis was determined by following release of hemoglobin into solution, and the percentage of dead HeLa or mcf-7 cells was
determined by resazurin assay. The averages and S.D. of three replicates are shown.
FIGURE 2.Bacterial cell permeabilization in the presence ofMac1. A–D, E. coliATCC29522 (A) and S. aureusATCC29523 (B) dispersed in PBS (107 cells/ml) or
E. coli ATCC29522 (C) and S. aureus ATCC29523 (D) dispersed inMHB (107 cells/ml) were incubatedwith various concentrations of Mac1 ormelittin at 37 °C for
1 h. Cell membrane permeabilization was detected by SYTOX Green fluorescence emission. The percentage of fluorescent cells was determined by flow
cytometry. Viable cells were determined by colony formation unit counts in LB agar plates. The averages and S.D. of six (A and B) or three (C and D) replicates
are shown.
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this estimation does not take into consideration the growth
inhibition induced by Mac1, nor any active membrane damage
repair, the concentration of Mac1 necessary to induce the
uptake of SYTOXGreen by E. coli and S. aureus remained well
under the MIC.
Mac1 Induces Greater Leakage from Charged Vesicles—CF
leakage assays were performed on vesicles mimicking the lipid
compositions of the bacterial and hRBC membranes. This dye
is similar in size to SYTOX Green used in the flow cytometry
(6.5 Å radius). The membrane disruption upon AMP titration
induces dequenching of the encapsulated dyes, and the increase
in fluorescence is used to assess the effect of specific lipid com-
position on Mac1 lytic activity. The concentration of Mac1
required to induce leakage in 50% of the vesicles (final lipid
concentration was 100 M) made of POPE/POPG lipids, which
mimic E. coli membranes, was 2-fold lower than from vesicles
made of POPG/TOCL lipids, which mimic the membrane of
S. aureus bacteria, with an LC50 of 2.8 0.1 and 5.4 0.2 M,
respectively. Interestingly, Mac1 has a low ability to induce
leakage from POPC/SM/Chol vesicles (LC50  16 M), here
used to model the outer leaflet of hRBC membranes (Fig. 3).
These results support the hypothesis that Mac1 has a greater
lytic activity against bacterial membranes than against hRBC
membranes but do not correlate with the MIC values obtained
for E. coli versus S. aureus and the LC50 obtained with hRBC.
To examinewhether the ability to induce vesicle leakage cor-
relates with ability to bind membranes, the affinity of Mac1 for
POPG/TOCL, POPE/POPG, and POPC/SM/Chol bilayers was
compared by surface plasmon resonance.Mac1 hasweak ability
to bind POPC/SM/Chol membranes (Fig. 4) but has the ability
to bind POPG/TOCL and POPE/POPG. A larger affinity for
POPG/TOCL suggests that the overall charge of themembrane
play a role in the Mac1 affinity for lipid bilayers and shows that
Mac1 prefers membranes that mimic the properties of Gram-
positive bacteria.
Mac1 Shows Greater Affinity for S. aureus versus E. coli
ModelMembranes in aCompetitive Assay—The lytic activity of
Mac1 was also investigated in conditions where vesicles with
distinct lipid composition were mixed (i.e. Gram-negative
model membranes mixed with Gram-positive model mem-
branes or models of hRBCmembranes mixed with either of the
bacterial membrane models) using an approach previously
developed to study the affinity of membrane-active peptide
within a competitive lipid environment (15). As shown in Fig. 5,
the concentration ofMac1 required to induce leakage in 50% of
CF-loaded POPE/POPG vesicles in the presence of POPG/
TOCL vesicles was 5-fold higher than in the situation with
POPE/POPG vesicles only (Table 2). The peptide did not
induce dye leakage from CF-loaded POPC/SM/Chol when in
the presence of POPE/POPG or POPG/TOCL vesicles. The
reverse experiments showed that the concentration of Mac1
required to induce 50% leakage from dye-filled POPG/TOCL
versus POPE/POPG or POPC/SM/Chol vesicles decreased by
2-fold (Table 2). The same effect was observed for POPE/POPG
vesicles mixed with POPC/SM/Chol vesicles. These results
show that in conditions in which S. aureus and E. coli model
membranes are mixed, Mac1 selects S. aureus model mem-
branes, not obvious in assays in which these two model mem-
branes are tested individually.
Membrane Depolarization Occurred at Similar Mac1
Concentrations—To evaluate whether Mac1 induces depolar-
ization of the anionic bacterial membrane, the electric mem-
brane potential of E. coli and S. aureus upon peptide titration
was determined via -potential measurements. The -potential
of S. aureus and E. coli bacteria was found to be 	13 and 	23
mV, respectively (Fig. 6). The titration of the cationic (1)
Mac1 peptide into the bacterial solutions induced a significant
shift toward neutral -potentials, inducing 55 and 35%
decreases of -potential for S. aureus and E. coli, respectively.
As expected, POPG/TOCL (100% anionic lipids) and POPE/
POPG (30% anionic lipids) membranes also exhibited negative
-potentials (Fig. 6) but more negative than obtained for both
bacteria, 	50.5 and 	39.5 mV, respectively, probably because
of the presence of other charged components inserted into or
adsorbed onto the bacterial membranes or the cell wall. The
-potential of POPG/TOCL and POPE/POPG vesicles upon
Mac1 titration increased by 60 and 40%, respectively, in a sim-
ilar trend as observed with S. aureus and E. coli -potentials,
although ionic concentration was slightly different.
FIGURE 3.CF leakage assays of POPC/SM/Chol (squares), POPE/POPG (tri-
angles), and POPG/TOCL (circles) LUV incubated with Mac1. Experiments
were performed at 37 °C. Curve fitting was achieved using a logistic model.
FIGURE 4. Binding of Mac1 to lipid membranes studied by surface plas-
mon resonance. A, sensorgrams obtained upon injection of 24 M over
POPC/Chol/SM (1:1:1 molar ratio), POPE/POPG (7:3 molar ratio), or POPG/
TOCL (3:2 molar ratio) bilayers for 220 s (association phase). The dissociation
from the membranes was followed after injection was stopped (dissociation
phase). B, dose-response binding of Mac1 for POPC/Chol/SM (1:1:1), POPE/
POPG (7:3), or POPG/TOCL (3:2) membranes. Peptide to lipid ratio (P/L mol/
mol) at the end of association phase was determined to normalize the
response to the total amount of lipid deposited onto chip surface (1 response
units 1 pgmm	2 of peptide or lipid).
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Mac1 Has Higher Helical Content in Charged Lipid
Systems—Determination of Mac1 secondary structure in the
presence of bacteria and hRBC by CD spectroscopy is impaired
because of a strong background signal from native proteins;
therefore, CD spectroscopy measurements were conducted
using PC/SM/Chol, PC/SM, PG/CL, PE/PG, LPS, CL, and PG
vesicles. The CD spectrum obtainedwithMac1 in buffer exhib-
ited a band with negative minimum at 190 nm, typical of
randomcoil structures, suggesting thatMac1 is unstructured in
aqueous environment, whereas in the presence of PE/PG or
PG/CL vesicles, the CD spectra possess two minima at 222
and 209 nmwith amaximum at200 nm, indicating dominant
-helical secondary structures (Fig. 7A). Acquisition of an
-helical conformation when in a membrane environment is
consistent with previous studies (13, 14). Interestingly, the CD
spectrum of Mac1 in the presence of PC/SM/Chol was similar
to the one obtained in buffer, indicating that themajority of the
peptidemolecules are in a random conformation, in agreement
withMac1 bindingweakly to this particularmembrane compo-
sition. Note that the PC/SM/Chol lipid-only background was
strong, because of the presence of SM lipids, and the spectrum
displayed in Fig. 7was smoothed after subtracting the lipid-only
background signal. The contribution of helical structure was
slightly higher in the presence of PG/CL (65%) than in the
presence of PE/PG (55%).
In the presence of LPSmicelles,Mac1 also acquired-helical
confirmation (47%) (Fig. 7A), suggesting that LPS does not pre-
vent peptide binding toE. colimembranes. Interestingly, higher
-helical content was obtained with POPG (65%) and TOCL
(60%) compared with POPC (40%) and POPC/SM (45%)model
membranes (Fig. 7C). These results indicate that Mac1 has a
greater, but not specific, affinity for anionic lipids (POPG versus
TOCL). Furthermore, the tight packing induced by the pres-
ence of Chol and SM inhibitedMac1 binding to the vesicles (see
POPC/SM/Chol versus POPC/SM and POPC in Fig. 7B).
Discussion
Relationship between LiveCells andMembraneModels—The
mechanism by which AMPs interact with bacteria or eukary-
otic cells is largely unknown because of the cell complexity;
elucidating the mode of action at molecular level is particularly
difficult because of challenges in identifying interactions
between peptides and complexes/domains within cells or cel-
lular downstream effects. To examine specific molecular inter-
actions, models are built to represent important features under
investigation. Unfortunately, the correlation between live cell
and membrane model experiments is too often deceptive. For
instance, Mac1 inhibits S. aureus at a lower concentration than
E. coli (Table 1), yet it disrupts model membranes that mimic
the composition of these cells within identical potency (Table 2
and Fig. 3), and it adopts a similar amphipathic helical struc-
ture, a key event in AMPs lytic activity, in both environments
(Fig. 7). Liposomes clearly are missing many important cellular
features, for instance the LPS layer of the outer membrane in
E. coli or the peptidoglycan layer in S. aureus. Although these
layers could significantly modulate the peptide lytic activity,
LPS did not prevent Mac1 adopting a helical structure (Fig. 7).
Interestingly, E. coli depleted of O-antigen chain on LPS was
more vulnerable to both peptides (Table 1), but SYTOX Green
uptake was similar to the type strain E. coli, indicating that a
thicker LPS layer did not prevent the peptides from damaging
the inner membrane. Also, -potential measurements sug-
gested thatMac1 exerts its action by direct interaction with the
anionic membranes rather than intracellular components, as
suggested by similar membrane potential reduction obtained
when Mac1 was incubated with bacteria or with model mem-
branes (Fig. 6). Finally, Mac1 lysed both E. coli and S. aureus
membranes at similar concentrations (Table 1, SYTOX Green
uptake assays), and therefore, in vitro and in vivo data presented
in this study trend to the same conclusion:Mac1 disruptsE. coli
and S. aureus with a similar mechanism.
So why such difference inMIC? A possibility to explain these
differences is the ability of bacteria to repair their damaged
membranes. This proposition requires further investigation,
and possibly E. coli (and Gram-negative in general) are more
efficient than S. aureus (Gram-positive) in maintaining their
membrane homeostasis (27), hence the differences in bacteri-
FIGURE5.CF leakageassayofMac1 titration intoacompetitive lipidenvi-
ronments made of 50 M of dye-filled LUV* and 50 M of dye-free LUV.
Left panel, effect of the presence of POPG/TOCL LUV on Mac1 lytic activity
against POPE/POPG* (triangles) and POPC/SM/Chol* (squares). Right panel,
reverse experiments investigating Mac1 lytic activity against POPG/TOCL*
LUV in the presence of POPE/POPG (filled circles) and POPC/SM/Chol (open
circles). Experiments were performed at 37 °C with 15min of incubation time
prior to measurements. Curve fitting was achieved using a logistic model.
TABLE 2
Mac1 lytic activity (LC50) in single and competitive lipid environments in terms of peptide per vesicles
The values are given in M. Aliquots of peptide were added to a fixed LUV concentration of 100 Mmade of equal amounts of dye-filled LUV* and dye-free LUV of similar
lipid composition for single environments, whereas competitive lipid environments were made by mixing dye-filled LUV* with dye-free LUV of a different lipid compo-
sition. The LC50 values were obtained fitting with a logistic function; errors are standard deviations of the fit.
POPC/SM/Chol* POPE/POPG* POPG/TOCL*
POPC/SM/Chol 16 1.1 0.2 2.1 0.1
POPE/POPG 16 2.8 0.1 2.1 0.2
POPG/TOCL 16 13.2 0.3 5.4 0.2
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cidal activities. This is supported by membrane disruption
observed in bacteria (Fig. 2) occurring at lower concentrations
than respective MIC (Table 1).
Electrostatic Interactions Modulate Mac1 Concentration at
the Membrane but Reduce Lytic Activity—The electrostatic
interactions between cationic AMP and negatively charged
membrane surfaces are commonly reported to explain the spe-
cific affinity for particular bacterial strains or against eukaryotic
cells (4, 28, 29). Thus, Mac1 was expected to possess a weak
ability to disrupt the neutral model membranes composed of
POPC/Chol/SM that mimic hRBC membranes but to strongly
compromise negatively charged vesicles that mimic S. aureus
or E. coli membranes. However, previous dye leakage experi-
ments have shown that Mac1 disrupts POPC vesicles with
greater efficiency than negatively charged membranes (15).
This indicates that not only are electrostatic interactions
important, but also the stiffness of the membrane can strongly
limit peptide binding to lipid bilayers. In particular, SM and
Chol that exist in high concentration in mammalian cells are
known to increase lipid membrane order and to segregate and
form more rigid domains (i.e. “raft”-like domains) in fluid cell
membranes (30). Lytic activity was considerably reduced in the
presence of Chol, which supports a likely role in protection of
the host cell. For instance, theAMPpardaxin has reduced back-
bone dynamics and channel forming activitywhen inserted into
cholesterol-rich POPC bilayers (31), and the presence of 25%
Chol in POPC bilayers reduces the insertion of gramicidin S
intomembranes, when compared with POPCmembranes (32).
The selectivity of AMPs toward bacterial membrane, over
mammalian cells, might be driven by the fluidity of the targeted
membrane. Binding and insertion into fluid membranes, but
not in more ordered membranes, is supported by the ability of
Mac1 to form helical structures in the presence of POPC (13)
and POPC/SM but not POPC/SM/Chol membranes (Fig. 7). A
weaker binding affinity prevented the formation of an
amphipathic helical structure that would allow the hydropho-
bic side to penetrate into the hydrophobic core of the mem-
brane with the hydrophilic side exposed to the aqueous
medium (33). A low ability to insert into liquid-ordered mem-
branes explains the low hemolytic activity of Mac1 (Table 1).
This is a hallmark ofmany pore-forming peptides that adopt an
amphipathic structure to self-associate into themembrane and
destabilize the membrane bilayer structure (2, 3, 28, 34).
Furthermore, electrostatic attractions were shown to
enhance the binding affinity of Mac1 toward membranes of
greater negative potential (Figs. 3–5), leading to an increase in
peptide helical content (Fig. 7). No significant differences were
FIGURE 6. Right panel, -potential of 200 M POPE/POPG 7:3 (triangles) and POPG/TOCL 3:2 (circles) LUV in 50 mM NaCl buffer (phosphate pH 7) and upon
titration of Mac1. Left panel, -potential of E. coli (triangles) and S. aureus (circles) at 107 colony formation units in PBS. Error bars are standard deviations from
three averaged experiments (100 runs per experiments) performed at room temperature with a 40 V potential.
FIGURE 7. CD spectra of Mac1 were obtained with 100 m Mac1 in the
presence of lipid vesicles at a lipid to peptide molar ratio of 50:1. A, LPS
micelles at 2 mg/ml (squares), POPE/POPG LUV (circles), and POPG/TOCL LUV
(triangles). B, buffer (squares), POPC (circles), POPC/SM (triangles), and POPC/
SM/Chol (stars). C, POPG (diamonds) and TOCL (octagons). The lipid back-
ground was subtracted, and three scans were accumulated at 37 °C.
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observed in the overall helicity of Mac1 when incubated with
POPG or TOCL bilayers. Because both lipids are anionic, the
structure of the anionic lipid is not a critical feature for AMP
binding affinity. However, Mac1 showed a lower ability to dis-
rupt and cause leakage of vesicles composed of 100% anionic
lipids (PG/CL membranes) than vesicles made with 30% ani-
onic lipids (PE/PGmembranes). Therefore, strong electrostatic
attractions between the peptide and the lipid headgroups not
only increase the peptide accumulation but may lock the pep-
tide at the membrane interface, reducing the penetration and
hence the peptide lytic activity. This effect can explain the low
anticancer activity of Mac1. Because cancer cells also possess
greater content of anionic membrane lipids than healthy cells,
the similar activity ofMac1 against HeLa andmcf-7 cells versus
red blood cells further supports a complex relation between
hydrophobicity and electrostatic interactions. Nature appar-
ently has designed an AMP for Australian tree frogs that is
specific to Gram-positive bacteria and not just cell membranes
with high anionic lipid content.
Finally, the important aspect in the development of novel
drugs is that AMPs confront several potential cellular targets,
which could dramatically affect their potency. For instance, we
have shown that although Mac1 can disrupt E. coli-like model
membranes, when in the presence of both E. coli- and
S. aureus-like membranes, the peptide has a preference for
S. aureus model membranes (Fig. 5). Therefore, by extrapola-
tion, we hypothesize that Mac1 could target and clear a
S. aureus infection before killing symbiotic E. coli bacteria or
becoming hemolytic.
Mode of Action of Mac1 against Cell Membranes—To better
develop AMP as viable alternatives or complements to classic
antibiotics, their mechanism of action should be determined.
This is a gargantuan task because themajority of these peptides
do not target a specific stereo-structure but instead adsorb onto
and insert into lipid bilayers via a multistep mechanism that is
likely dependent on the lipid composition of the membrane
(13).
Through this study, it was shown that binding affinity toward
a negatively charged membrane is not the sole parameter that
modulates the ability ofMac1 to bind and disrupt lipid bilayers.
In fact, a complex ratio between surface charge and membrane
order is likely to promote the optimal peptide activity and thus
may be responsible for the specific antibacterial concentra-
tions. The difference in fluidity or membrane order between
E. coli membrane and S. aureus membrane should be further
investigated. Nevertheless, Mac1 was shown to preferentially
bind S. aureus-likemembranes, with the greater negativemem-
brane potential, than E. coli membranes, and a higher mem-
brane-bound peptide population could also be responsible for
the respective bactericidal concentrations.
Finally and importantly, we indirectly demonstrated that
bacteria can repair their injured membranes in nutrient-rich
medium or sustain heavy membrane damage before growth
inhibition occurred. Indeed, Mac1 disrupted the lipid mem-
brane structure of E. coli and S. aureus with a similar mode of
action, but inhibition occurred atmuch greater concentrations.
Therefore, we propose that on top of the specificmode of action
of AMP, bacterial membrane repair and the ability to sustain
different amounts of damage may modulate the bactericidal
potency.
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